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Abstract
Oral route is preferred for drug administration; however according to the
recent scenario 40% of new drug candidates have poor water solubility and low
bioavailability. One of the biggest challenges in drug delivery science is to improve
low oral bioavailability problem which is associated with the hydrophobic drugs
due to their unprecedented potential as a drug deliver with the broad range of
application. Self-emulsifying systems have been proved as highly useful technolog-
ical innovations to vanquish such bioavailability problem by virtue of their dimin-
utive globule size, higher solubilization tendency for hydrophobic drugs, robust
formulation advantages, and easy to scale up. Self-microemulsifying systems are
isotropic mixers of oil, surfactant, drug and co-emulsifier or solubilizer, which
spontaneously form transparent micro-emulsions with oil droplets ranging between
100 and 250 nm. Micro emulsified drug can be easily absorbed through the lym-
phatic pathway and it bypasses the hepatic first-pass effect. Self-microemulsifying
system is a thermodynamically stable system and overcomes the drawback of
layering of emulsions after sitting for a long period of time. The present literature
gives exhaustive information on the formulation design and characterization of
self-microemulsifying systems.
Keywords: self-micro emulsifying systems, bioavailability, lipid base formulation,
surfactant
1. Introduction
An advance in in-vitro screening methods such as conjunctional chemistry is
leading to publicizing of many potential chemical components with high therapeu-
tic activity. Such rapid identification of highly potent pharmaceutical lead com-
pounds has optimized pharmacodynamic properties but sub-optimal
biopharmaceutical characteristics [1]. Most of the drugs are lipophilic in nature and
has poor water solubility. Such low water solubility becomes the major challenge
in successful development of their oral formulation. Also several drug compounds
has low oral bioavailability which further enhances the challenge for the formulator
scientist [2, 3]. More than 40% of drugs are lipophilic in nature with poor water
solubility. To resolve such challenges, many approaches have been reported to
improve the solubility and enhance the oral bioavailability which includes the
formation of cyclodextrin complex, lipid based drug delivery system, solid disper-
sions, micronization, etc. [4, 5]. Among these methods, self-emulsifying systems is
one of the most optimistic approaches to enhance the oral bioavailability of poorly
water-soluble drugs since it maintains the drug in a solubilized state in the gastro-
intestinal tract [6]. A stable self-micro emulsifying system consists of mixture of
drug, oil, surfactant and co-surfactant. Upon dilution with water it results into fine
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oil-in-water emulsion with a droplets diameter less than 50 nm [7, 8]. The micro-
emulsion droplet of self-micro emulsifying systems entraps the drug molecule
completely with 100% efficacy, thus self-micro emulsifying systems shows high
potential to deliver low water soluble drug [9]. Rapid emulsion formation helps to
keep the drug in a dissolved form and small droplet size offers a considerably larger
interfacial surface area which further accelerates the absorption rate of drug with
limited solubility. Moreover, the droplets can be rapidly dispersed in blood as well
as lymph and the lymphatic drug transport can avoid the first-pass effect [10]. This
feature makes self-micro emulsifying systems a significant choice for oral delivery
of lipophilic, low bioavailable drugs having ample of lipid solubility [11–14]. Self-
emulsifying systems is a broad term which produces emulsions with a droplet size
ranging from a few nanometers to several microns. A self-micro emulsifying system
indicates the formulations forming transparent micro-emulsions with oil droplets
ranging between 100 and 250 nm. Term self-nano emulsifying system is used to
characterize the system which results into emulsion with globule size less than
100 nm [15, 16].
2. Self-micro emulsifying systems
2.1 Classification of lipidic formulations
Lipidic formulations are classified as Type I, II, III, and IV based upon excipients
used. Type I formulations are non-self-emulsifying whereas Type II, III, and IV
formulations are self-emulsifying. Type of emulsion formed after dilution of self-
emulsifying system with water, depends upon the excipients used in formulation.
Digestibility of lipidic compositions is also affected by these ingredients. Elements
of lipidic systems are represented in the proceeding portion [17, 18]. Classification
system of lipid formulation is shown in Table 1.
Type I: Drug with tri-, di- or monoglyceride in lipid based compositions is called
as type I formulations. Dilution of type I formulations with aqueous media creates
Formulation Excipients Properties Pros Cons
Type I Oils lacking of
surfactants (e.g. tri-,di-
and mono glycerides)
Not dispersing,
it needs
digestion.
Simple,
Compatibility is
excellent for
capsule.
Formulation has
poor solvent
capacity unless drug
is highly lipophilic.
Type II Oils and water-insoluble
surfactants.
SES formed
without water-
soluble
components
Unlikely to lose
solvent capacity on
dispersion
Turbid o/w
dispersion
(particlesize0.25–
2 mm)
Type III Oils, surfactants and co
solvents (both water
insoluble and water-
soluble excipients)
SES/SMES
formed with
water-soluble
components
clear or almost
clear dispersion;
drug absorption
without digestion
Possible loss of
solvent capacity on
dispersion; less
easily digested
Type IV Water-soluble
surfactants and Co
solvents(no oils)
Formulation
disperses
typically to
forma micellar
solution
Formulation has
good solvent
capacity for many
drugs
Likely loss of
solvent capacity On
dispersion; might
not be digestible
Table 1.
The Lipid Formulation Classification System: characteristic features, pros and cons of the four essential types of
‘lipid’ formulations.
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coarse dispersion and is not readily dispersible. Initial digestibility by pancreatic
lipase/co-lipase to engender more amphiphilic species is a pivotal necessity for their
oral absorption. For potent drugs or drugs with high oil solubility, Type I formula-
tions are preferable.
Type II: These formulation contain drug with oil and water insoluble surfactants
(Hydrophilic lipophilic balance <12), and are also called as self-emulsifying sys-
tems. Self-emulsification is mainly acquired at the surfactant concentration above
25% w/w. Surfactant greater than 60% w/w that is at higher Concentration, there is
formation of liquid crystalline gel phases at the o/w interface because emulsification
is impeded. Such systems generate droplets size above 300 nm, when dispersed in
water it developed emulsion which is opaque in nature.
Type III: Type III formulations consist of drug, oil, surfactants, and co-solvents
for both water-soluble and water insoluble. Ethanol, polyethylene glycol and pro-
pylene glycols are selected as co-solvents. Such systems generate droplets size below
300 nm, when dispersed in water and are called as self-micro emulsifying systems.
The obtained emulsion is either optically clear or somewhat opalescent dispersion.
Type IV: Type IV formulations consist of drug, water soluble surfactants, and
co-solvents. Oil is absent in this type of formulation.
2.2 Suitable drug candidate identification for self-emulsifying systems
Drugs that belong to the Class II and Class IV of biopharmaceutical classification
system offer potential platform to enhance the oral bioavailability. Log P of the drug
indicates the potential utility of lipid based formulation. Maintenance of drug solu-
bility in gastrointestinal tract is the foremost challenges to oral formulation and
especially the increased drug solubility at the absorption site of the gut [19]. Lipo-
philic drug composite that manifest dissolution rate limited absorption, self-
emulsifying systems can provide an improvement in absorption in terms of rate and
extent, that results in consistent blood time profiles [7, 20]. Problem of poor solu-
bility and low bioavailability of drug across all categories of biopharmaceutical
classification system can be resolved by formulating into self-emulsifying system,
as shown in Table 2 [21].
For an oral absorption Lipinski’s rule of five has been widely proposed as a
qualitative predictive model. In the discovery setting, the ‘rule of five’ predicts that
if there are more than five H– bond donors, it shows poor absorption or poor
permeation [22].
Whether solubility and log P are sufficient to identify probable drug candidates
for such formulations that question arises and also it is noted that biopharmaceuti-
cal classification system and Lipinski’s rule of five classification system are useful,
particularly at inceptive screening stage, they have some constraint. For recognize
the suitable lipid based formulation approach aqueous solubility and log P alone are
improbable enough because they do not adequately predict potential in- vivo
effects.
BCS class Hurdles overcome by SES
Class I Gut wall efflux, Enzymatic degradation.
Class II Solubility and bioavailability.
Class III Enzymatic degradation, bioavailability and gut wall efflux.
Class IV Solubility, bioavailability, Enzymatic degradation, gut wall efflux.
Table 2.
SES as a solution to various problems to different classes of drugs.
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2.3 Choice of self-microemulsifying excipients for formulations
Self-emulsifying formulation produces dispersion in gastrointestinal tract by
using different excipients. Isotropic mixtures of oils, surfactants, solvents, and co-
solvents/surfactants comprise self-emulsifying formulation and it emulsifies in gas-
trointestinal tract under a gentle agitation [23].
Depending upon the type of dispersion produced after dilution with water
phase, self-emulsifying formulations are further classified as self-emulsifying sys-
tems, self-micro emulsifying systems and self-nano emulsifying systems. Emulsion
which is slightly hazy, opalescent or opaque colloidal coarse dispersion is called as
self-emulsifying systems. Micro-emulsion which is clear or pellucid, slightly hazy,
opalescent, non-opaque colloidal dispersion with droplet size below 150 nm are
called as self-micro emulsifying systems. Nano-emulsion which clear or pellucid,
slightly hazy, opalescent, non-opaque or substantially non-opaque colloidal disper-
sion with droplet size below 20 nm in diameter called as self-nano emulsifying
systems [24]. For the formulation, excipient should be chosen from the list of
generally regarded as safe “GRAS” excipients published by USFDA or from other
inactive ingredients approved and published by regulatory agencies.
2.3.1 Active pharmaceutical ingredient
Active Pharmaceutical Ingredient should be soluble in oil phase as this have an
impact on the self-micro emulsifying systems to maintain the active pharmaceutical
ingredient solubility. Drugs with the low solubility in aqueous media or lipids are
strenuous to convey through self-micro emulsifying systems. Exceedingly good
solubility in one of the components of self-micro emulsifying systems is require
preferably oil phase, if very high dose of drug liked to be administered. For self-
micro emulsifying systems, high melting point of drug with log P value around 2 is
not appropriate and for self-micro emulsifying systems, lipophilic drugs with the
log P values more than 5 are good candidate [19, 25].
2.3.2 Lipids/oils
In self-emulsifying formulations, oil represents the most important constituent
as it solubilizes prominent amounts of the lipophilic drug. Oil promotes self-
emulsification and extends the fragment of lipophilic drug transported through the
intestinal lymphatic system. Absorption of lipophilic drug from the gastrointestinal
tract is enhanced depending upon the molecular nature of the triglyceride used in
formulation [26, 27]. Regardless of the noteworthy potential that these lipid excip-
ients have, very few of lipid based formulations has reached to the pharmaceutical
market. This may be due to the insufficient data concerning the relatively compos-
ite physical chemistry of lipids and scrutinize about formulated drug chemical and
physical stability. Incorporation to these studies, its impact on drug absorption is
also essential and which depends on interaction of a lipid-based formulation with
the gastrointestinal tract environment [28]. Natural edible oils, comprising
medium-chain triglycerides, are not commonly preferred in this regard owing to
their poor ability to dissolve large amounts of lipophilic drugs [29]. For designing of
self-emulsifying systems, varying degrees of saturated and hydrolyzed long and
medium chain triglycerides are used. These semi synthetic derivatives form good
emulsification systems when used with a large number of solubility enhancing
surfactants approved for oral administration. There is polarity deference between
the long chain triglyceride and medium-chain triglyceride, a wide micro-emulsion
area has been achieved in phase diagram if medium chain triglyceride is used. More
is hydrophobic long chain triglyceride, more difficult it becomes to emulsify.
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2.3.3 Surfactants
The self-emulsifying system demand incorporation of comparatively large
amounts of surfactant in addition to the oil, to convey drug in the formulation.
Permeability of the intestinal membrane and affinity between lipids and intestinal
membrane will be improved due to effect of surfactant. Surfactants improve the
permeability by partitioning into the cell membrane and disrupting the structural
organization of the lipid bilayer dominates to permeation enhancement [30]. The
two major affairs that command the selection of a surfactant enclose first safety and
second hydrophilic lipophilic balance. To formulate self-emulsifying systems,
Hydrophilic lipophilic balance of surfactant provides important information. High
emulsifying performance is achieved if the emulsifier used in formulation of self-
emulsifying systems has high hydrophilicity and hydrophilic lipophilic balance.
Therefore, for effective absorption at the site, drug is present in solubilized form for
a longer period of time and prevents precipitation of drug substance in gastrointes-
tinal tract lumen [31]. Generally single alkyl chains are more penetrative, so surfac-
tants such as polysorbates and triglyceride ethoxylates are found to be less toxic.
Usually the surfactant concentration ranges between 30 and 60% of the total for-
mulation in order to form stable self-micro emulsifying systems [32].
2.3.4 Co-surfactants/co-solvents
Stress of interface is decrease in the presence of co-surfactant and it allows the
interfacial film sufficient flexibility to take up different curvatures required to
form self-micro emulsifying systems over a wide range of composition [33]. The
mixture with higher surfactant and co-surfactant: oil ratio assists the formation of
self-micro emulsifying systems. Disadvantage of alcohol and other volatile co-
solvents is that they get evaporated through the shell of soft or hard gelatin capsules
and results into precipitation of drug (Table 3) [34, 35].
2.4 Mechanism of self-emulsifying systems
The mechanism by which self-emulsification occurs is not yet well understood.
The entropy change of dispersion is greater than the energy required to increase the
surface area of the dispersion at that time self-emulsification is occurring. In a
conventional emulsion formulation, a free energy is an energy that required
developing a new surface between the two phases i.e. oil and water and it can be
narrated by
Oils Surfactants Co-surfactants/
co-solvent
Cotton seed oil Polysorbate 20 (Tween 20) Span 20
Soybean oil Polysorbate 80 (Tween 80) Span 80
Corn oil Polyoxy 35 castor oil (Cremophor RH40) Capryol 90
Sunflower oil Polyethylene glycol
Castor oil D-alpha Tocopheryl polyethylene glycol 1000 succinate
(TPGS)
Ethanol
Peanut oil Lauroglycol
Sesame oil Isopropyl alcohol
Table 3.
Example of Oil, Surfactant and Co-surfactant/Co-solvent.
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ΔG ¼ ΣNπr2σ (1)
where G is free energy, N is the droplets number, r is globules radius, and σ is
the interfacial energy [22, 26]. The oil and water phase of the emulsion separates
upon reduction in the interfacial area and free energy of the system. Conventional
emulsifying agent stabilizes the emulsion by forming a monolayer around the
emulsion droplets and reduces the interfacial energy, thereby provides a barrier to
coalescence. For the formulation self-emulsifying systems free energy requires is
either very low or positive or negative then, the emulsion process occurs irrepress-
ible. Very low energy requires for emulsification, it involves destabilization through
diminution of interfacial regions. It is necessary to not have any resistance to the
surface shearing of the interfacial structure to occur the emulsification. Through the
emulsification water penetrates into the various liquid crystals or phases. As soon as
binary mixture of oil/non-ionic surfactant comes in contact with aqueous phase,
formation of interface between the oil and aqueous phases occurs. Aqueous phase
penetrates through this interface and starts solubilizing with oil phase till the limit
of solubilization is reached at the interface. There is relationship between the emul-
sification properties of the surfactant and phase inversion behavior of the system.
Upon mild agitation of self-micro emulsifying systems, water penetration occurs
quickly and leads to the interference of interface and droplets will be formed as
micro-emulsions are thermodynamically stable; equilibrium exists within the sys-
tem although there is continuous exchange of matter between the different phases
[36]. Interchanging of matter usually occurs in two different ways like amalgam-
ation of small droplets followed by the parting of larger droplet into small droplets
and fragmentation of droplets which later coagulate with other droplets [37].
Self-emulsifying drug delivery system also poses accountability in contempt of
its many assets namely
i. Drug chemical instability
ii. Large amount of surfactant used in formulation causes irritancy in
gastrointestinal tract
iii. Precipitation of lipophilic drugs take place when volatile co-solvent is
incorporated [38].
2.5 Formulation design
Formulation of self-micro emulsifying systems involves the following steps.
1.Screening of excipients.
2.Establishment of pseudoternary phase diagram.
3.Development of self-micro emulsifying systems.
4.Characterization of self-micro emulsifying systems.
2.5.1 Screening of excipients
Selection of the most satisfactory excipients that can be used in the preparation
of self-micro emulsifying systems depends on the solubility studies. Solubility of the
drug is tested in various oils, surfactants, and co-surfactants [39]. Shake flask
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method is generally used to performed these type of studies. In these studies excess
amount of drug is added to the excipient and then flask is shaken for 48 hours in
water bath shaker at room temperature. After 48 hours samples are subjected to
centrifugation, then filtered through 0.45 μm filters and drug content is examined
[40, 41]. The objective of these solubility studies is to choose oil, surfactant, and
co-surfactant that show maximum solubility to the drug. Another objective is
accomplishment of optimal drug loading with minimized entire volume of the
formulation [42].
To check the emulsification ability, screening of surfactant and co-surfactant is
done by mixing known amount of surfactants with equal portion of selected oil and
surfactant, and homogenized. The idea about ease of emulsification is obtained
when the mixture is added to double distilled water and the number of flask
inversions required to form homogenous emulsion is noted [43]. Then, the obtained
dilution is tested for turbidity, percentage transmittance and clarity. The surfactant
that shows high percentage transmittance at lower flask inversions with high emul-
sification efficiency is generally selected. Similarly, co-surfactants representing
higher emulsification efficiency are selected for self-emulsifying formulation [44].
2.5.2 Construction of pseudoternary phase diagram
Micro-emulsion is formed by the spontaneous emulsification method and can
be depicted with the help of phase diagrams. Construction of phase diagram is a
useful approach to study the complex series of interactions that can occur when
different components are mixed ternary phase diagram is used to study the phase
behavior of three components. Ternary phase diagram represents the system with
three components oil, water, and surfactant. But in case of self-micro emulsifying
systems, the additional component like co-surfactant/co-solvent addition is most
common. Ternary diagram contains three corners that correspond to the 100% of
the particular component. In case of addition of fourth component, the ternary
diagram can be termed as pseudoternary phase diagram [45]. For building of
pseudoternary phase diagram, components of micro-emulsion are examined for
emulsification efficiency at various compositions. Emulsions, micro-emulsions,
micelles, inverted micelle structures may be form and the degree of formation of
these structures can be determined with the formation of ternary phase diagram
[46, 47]. The fixed ratio is typically formed by the fusion of surfactant and co-
surfactant and it may be the mixture of oil and surfactant. This is mixed with the
specific volume of the third phase like oil or co-surfactant; then the other compo-
nent i.e. water is added in a gradual amounts and with every addition the solution is
tested for the clarity, dispersibility, time for self-emulsification, and flowability.
The total concentration of all components in each mixture is 100%. In
pseudoternary phase diagram, the samples which formed clear solution is denoted
by suitable symbols in the phase diagram. The area that is formed when these points
are joined indicates the mono-physic micro-emulsion existing area and wide area
indicates the good emulsification efficiency [48, 49].
The following points may be useful to read and to understand ternary diagram in
an easy way. The three corners of the typical ternary diagram represent three
components, that is, A, B, and C. The arrow towards BA indicates increase in
proportion of A from 0% concentration (at point B) to 100% concentration (at
point A), the arrow towards AC indicates the increase in proportion of C from 0%
concentration (at point A) to 100% concentration (at point C), and similarly the
arrow towards CB indicates the increase in proportion of B from 0% concentration
(at point C) to 100% concentration (at point B). It shows in Figure 1, composition
at point O can be known by the following procedure [50].
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i. A line is drawn parallel to CB from point O towards AB. The point where this
line intersects with AB indicates the percent composition of A at point O (X).
ii. Then, percent composition of B at point O can be known by drawing a line
that is parallel to AC towards BC. The point where this line intersects with
BC indicates the percent composition of B at point O (Y).
iii. Similarly, the percent composition of C, at point O can be known by
drawing a line that is parallel to AB towards AC (Z).
2.5.3 Preparation method of self-micro emulsifying systems
Self-micro emulsifying systems is prepared by adding drug into the mixture of
oil, surfactant, and co-surfactant and then vortexed. In some methods, first drug is
dissolved in one of the excipients and later on other excipients are added to this
prepared solution. Then, the solution is appropriately mixed and turbidity mea-
sured. After 48 hours at climatic condition, the solution is heated if required for the
development of clear solution [51, 52].
2.5.4 Characterization of self-micro emulsifying systems
2.5.4.1 Visual inspection
The assessment of self-emulsification is possible by visual evaluation. After
dilution of self-micro emulsifying systems with water, the opaque and milky white
appearance indicates the formation of macro emulsion whereas the clear, isotropic,
transparent solution indicates the formation of micro-emulsion [53, 54]. Precipita-
tion of drug in diluted self-micro emulsifying systems is evaluated by visual inspec-
tion. The stable formulation is obtained when drug precipitation is not noticeable. If
Figure 1.
Typical ternary diagram indicating the composition of A, B, and C at point O.
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the formulation contains water soluble co-solvents then precipitation is common
outcome and it can be avoided by enhancing the concentration of surfactant
[55, 56].
2.5.4.2 Droplet size
This is a crucial factor in self-emulsification performance because it determines
the rate and extent of drug release, as well as the stability of the emulsion [57]. The
droplet size is mainly dependent on the nature and concentration of surfactant.
Photon correlation spectroscopy, microscopic techniques or a coulter nanosizer are
mainly used for the determination of the emulsion droplet size [58, 59].
2.5.4.3 Turbidity measurement
This recognizes efficient self-emulsification by determine the dispersion
reaching equilibrium quickly in a consistent time [60]. Orbeco-Helle turbidity
meter is most commonly used for turbidity measurements. This turbidity meter is
connected to dissolution equipment and emulsification time, optical clarity of nano
or micro-emulsion formed is recorded after every 15 second. Turbidity can also be
discovered in expression of spectroscopic characterization of optical clarity [61].
2.5.4.4 Zeta potential measurement
This is used to identify the charge of the droplets. In conventional self-micro
emulsifying systems, the charge on an oil droplet surface is negative because of the
presence of free fatty acids. Zeta potential is generally measured by zeta potential
analyzer or zeta meter system [11]. Value of zeta potential indicates the stability
of emulsion after appropriate dilution. Higher zeta potential indicates the good
stability of formulation [62, 63].
2.5.4.5 Viscosity measurement
Viscosity of diluted self-micro emulsifying systems formulation is determined
by rheometers like brookfield, cone and plate rheometers fitted with cone spindle or
rotating spindle brookfield viscometer. During titration, the initial increase in vis-
cosity with subsequent decrease with the increase in water volume attributes to
water percolation threshold. This indicates the formation of o/w micro-emulsion
from w/o micro-emulsion with intermediate bi-continuous phase [64]. Micro-
emulsion can be determined by the graph plotted between shear stress and shear
rate. The Newtonian behavior indicates the presence of droplets of small and
spherical shape.
2.5.4.6 Determination of emulsification time
Efficiency of emulsification of various compositions of medium chain triglycer-
ide systems is determined by using a rotating paddle to assist emulsification in a
crude nephelometer [65]. This empowers an assessment of the time taken for
emulsification.
2.5.4.7 Cloud point determination
Cloud point is generally determined by gradually increasing the temperature of
water bath in which the formulation is placed and measured spectrophotometrically.
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The point where percentage transmittance decreases signifies the cloud point that is
the temperature above which the transparent solution changes to cloudy solution.
As the body temperature is 37°C, formulations should exhibit the cloud point more
than body temperature to retain its self-emulsification property. Phase separation
and decrease in drug solubilization are commonly observed at higher temperature
than the cloud point due to the susceptibility of surfactant to dehydration.
Cloud point is influenced by drug lipophilicity and other formulation
components [66].
2.5.4.8 Cryo-transmission electron microscopy studies
Transmission electron microscope is used to characterize the sample. In this
sample is taken on copper grid. Filter paper is used to form the thin liquid film on
the grid. The grid is extinguished in liquid ethane at 180°C and transferred to
liquid nitrogen at 196°C [67, 68].
2.5.4.9 Percent transmission
This test gives the indication of transparency of diluted self-micro emulsifying
systems formulation. It is determined spectrophotometrically after dilution of for-
mulation with water, keeping water as blank. The percentage transmittance value
near to 100% indicates clear and transparent micro-emulsion formation [69].
2.5.4.10 Small-angle neutron scattering
Size and shape of the droplets is determined using small angle neutron scatter-
ing. Small-angle neutron scattering experiments use the interference effect of wave
lets scattered from different materials in a sample with the different scattering
length densities.
2.5.4.11 Thermodynamic stability study
These studies are useful to evaluate the consequence of temperature change on
formulation. Formulation is diluted with aqueous phase and subjected to centrifu-
gation at 15,000 rpm for 15 min or at 3500 rpm for 30 min. The samples in which
the phase separation is not observed further subjected to freeze thaw cycles (20
and 40°C temperature, respectively) and observed visually. The thermodynami-
cally stable formulations does not show any changes in visual description [70, 71].
2.6 Factors influencing formulation of self-micro emulsifying systems
2.6.1 Drug dose
Drugs with a very high dose are not acceptable for self-micro emulsifying sys-
tems unless they exhibit very good solubility in one of the excipients of self-micro
emulsifying systems, mostly in a lipophilic phase. The drugs having a little solubility
in water and lipids (log P values of approximately 2) are very difficult to deliver by
self-micro emulsifying systems.
2.6.2 Drug solubility
Solubility of the drug in oil phase is important parameter in self-micro emulsifying
systems formulation to maintain the drug solubility. A chance of precipitation is
probably higher if contribution of surfactant and co-surfactant is greater in
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formulation. Dilution of self-micro emulsifying systems will owe to decrease solvent
capacity of the surfactant or co-surfactant. An equilibrium solubility measurement is
carried out to predict the potential cases of precipitation in the gut region.
2.6.3 Polarity of lipid phase
Drug release from the self-micro emulsifying systems is mainly affected by the
polarity of the lipid phase. The polarity of the droplet is governed by the hydrophilic
lipophilic balance, the chain length and degree of unsaturation of the fatty acid,
the molecular weight of the hydrophilic portion and the concentration of the
emulsifier. Affinity of drug towards solvent is indicated by polarity. Rapid release of
the drug in the aqueous phase is high if the polarity is high.
2.7 Significance of self-micro emulsifying systems
1.Self-micro emulsifying systems have the same advantage as emulsions, of
facilitating the solubility of hydrophobic drugs. Macro-emulsions undergo
creaming over a period of time, whereas self-micro emulsifying systems being
thermodynamically stable can be stored easily [22].
2.Most of the self-micro emulsifying systems formulations are in capsule or
tablet dosage forms, thus occupying smaller volume, easy to administer and
hence improved patient compliance [72].
3.Self-micro emulsifying systems are advantageous over self-emulsifying
systems as the former is less dependent on bile salts for the formation of
droplets [73].
4.Drugs which have propensity to be degraded by the chemical and enzymatic
means in gastrointestinal tract can be protected by the formulation of self-
micro emulsifying systems as the drug will be presented to the body in oil
droplets [74].
5.Self-micro emulsifying systems have the ability to facilitate rapid oral
absorption of the drug, which results in quick onset of action [75].
6.Absorption of drug from self-micro emulsifying systems formulation is not
affected by food. The lipophilic contents of fatty diet, aids in absorption of
drug from these systems [76].
7.Self-micro emulsifying systems can be easily manufactured at large scale as it
requires simple and economical manufacturing facilities, such as simple mixer
with an agitator and volumetric liquid filling equipment [77].
8.Surfactants of high hydrophilic lipophilic balance like polysorbate 80 are
reported to increase the permeability of the drug when administered along with
the formulation due to the loosening effect of these on tight junctions [78].
2.8 Challenges in self-micro emulsifying systems formulation
1.In gastrointestinal tract fluid, diluted self-micro emulsifying systems undergo
precipitation of drug. An essential for the lipid formulations is that they should
allow keeping the drug in the solubilized form in the gastrointestinal tract.
Advantage of lipid-based formulation is abolished due to the precipitation of
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the drug. The precipitation tendency of the drug on dilution is higher due to
the dilution effect of the hydrophilic solvent. It thereby requires incorporation
of polymers to minimize drug precipitation in-vivo [79, 80].
2.Liquid self-micro emulsifying systems are difficult during handling, storage
and stability. Therefor formulating solid self-micro emulsifying systems seems
to be a logical solution for these problems [81]. Another hurdle in the
development of self-micro emulsifying systems and other lipid-based
formulations is the lack of good established in-vitro models for the assessment
of the formulations [79].
3.Conventional dissolution methods do not work, as these formulations
potentially are dependent on digestion of lipid in the gut, earlier to release of
the drug. In-vitro model replicating the digestive processes of the duodenum
has been developed to mimic the condition [81]. This model also needs more
clarification and validation before its strength are examined. Further,
development can be based on in vitro–in-vivo correlations.
4.Lipid excipients containing unsaturated fatty acids and its derivatives are
prone to lipid oxidation [81]. Inclusion of Lipid soluble antioxidant in
formulation of capsule [82]. Polymorphism associated with thermo-softening
lipid excipients requires specific process control in their application, in order
to minimize polymorphic changes of the excipient matrix.
2.9 Patented conventional self-micro emulsifying systems of lipophilic drugs
Self-micro emulsifying systems patent are shown in Table 4 [83–86].
Sr. no Summary of invention Application Patent number
1 Self-microemulsifying formulation
containing taxoid, surfactant, and Co-
surfactant [22].
Poorly water soluble compounds
Taxoids having high molecular
weight, and slightly lipophilic. This
patent enhances oral bioavailability
of taxoids through
self-emulsification.
EP1498143A1
2 The self-micro emulsifying
Formulation consisting of poorly
soluble or insoluble drug, vitamin E, a
co-solvent, bile salt(s), TPGS, and a
surfactant [72].
Increases bioavailability of poorly
soluble drugs of paclitaxel and
docetaxel.
EP1340497A1
3 Self-emulsifying pharmaceutical
Composition containing a lipophilic
drug, surfactant(s), and hydrophilic
carrier(s) [73].
Improves bioavailability of poorly
soluble drugs such as cyclosporine,
tacrolimus, ibuprofen, ketoprofen,
nifedipine, amlodipine, and
simvastatin.
EP2062571A1
4 Formulation containing mitotane,
propylene glycol monocaprylate,
propylene glycol dicaprate, and
polyoxyethylene sorbitanmonooleate
[74].
The invention provides the SMES of
mitotane, which overcomes the issue
of its low solubility and low
bioavailability.
EP2435022A2
Table 4.
Patented conventional SMES of lipophilic drugs.
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3. Conclusion
Self-micro emulsifying systems drug delivery systems are effective approach for
increase the bioavailability of poor water soluble drug. Currently, several formula-
tions have been developed to produce modified emulsified formulations as alterna-
tives to conventional self-emulsifying systems, which provide faster and enhanced
drug release. Versatility of self-micro emulsifying systems could be proved if issues
like method to predict solubilization state of the drug in-vivo, interaction of lipid
systems with components of capsule shell and basic mechanism of transport of self-
micro emulsifying systems through gastrointestinal tract are adequately addressed.
Further research in developing self-micro emulsifying systems with surfactants of
low toxicity and to develop in-vitro methods to better understand the in-vivo fate of
these formulations can maximize the availability of self-micro emulsifying systems
in market.
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